IR-Med raises $31,200 via insider convertible notes; director Avital Rosenberg resigns

IR-Med, Inc.

Aggregate $31,200 unsecured convertible notes issued to three insiders (Ran Ziskind, Yaniv Cohen, Oded Bashan).
Each note $10,400 principal, 9% simple interest, due March 26, 2026 or upon $100k+ financing.
Conversion at maturity at 85% of closing price of common stock.
Director Avital Rosenberg resigned March 27, 2024, effective immediately, no disagreement.
Notes issued under Section 4(a)(2) exemption as unregistered sale.

item 3.02 item 1.01 item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Avital Rosenberg

director

IR-Med, Inc.

Effective: 2024-03-27
Filed: April 1, 2025, 7:59 PM ET

On March 27, 2024, Ms. Avital Rosenberg notified the board of directors (the “Board”) of the Company of her resignation from the Board, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Avital Rosenberg resigned as director at IR-Med, Inc..

Action: resigned
Role: director

Exact text from the filing

On March 27, 2024, Ms. Avital Rosenberg notified the board of directors (the “Board”) of the Company of her resignation from the Board, effective immediately.

View on SEC.gov

Source: SEC EDGAR

accession 0001641172-25-002067

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.